Search results
Zacks Research Comments on Bristol-Myers Squibb’s FY2024 Earnings (NYSE:BMY)
ETF DAILY NEWS· 5 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Zacks Research issued their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 4 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance via AOL· 17 hours agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings...
Bristol Myers Squibb reports setback in lung cancer trial By Investing.com
Investing.com· 4 days agoBristol Myers Squibb (NYSE: NYSE:BMY) disclosed that its Phase 3 CheckMate -73L trial for treating a...
Cytokinetics Slumps Despite 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 14 hours agoCytokinetics stock slumped Monday despite seemingly positive test results for its Bristol Myers...
Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 6 days agoMany Bristol-Myers Squibb Company (NYSE:BMY) insiders ditched their stock over the past year, which...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill· 6 days agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
News Highlights: Top Company News of the Day - Friday at 7 PM ET
Morningstar· 3 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its primary endpoint. The television company, which produces "The Walking Dead," cited "declines ...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 24 hours agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 4 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...